CompletedNot Applicable

Early Clinical Experience With Anidulafungin In Patients With Liver Disease In The United Kingdom

United Kingdom50 participantsStarted 2011-02

Plain-language summary

The purpose of this study is to describe the real world effectiveness of anidulafungin in clinical practice in a large Liver Unit in the United Kingdom.

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Subjects who have been prescribed anidulafungin between 1st July 2009 and 30th September 2010. Patients admitted to specialist liver unit wards and the Liver Intensive Therapy Unit during this period Exclusion Criteria: * Patients who participated in any interventional clinical trial during this episode of sepsis. Patients who received anidulafungin for infection prophylaxis

What they're measuring

Percentage of Participants With Favorable Outcome

Timeframe: Day 28 post-treatment

Trial details

NCT IDNCT01202253

SponsorPfizer

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2011-05

Results submitted2012-04-06

View on ClinicalTrials.gov More Candidiasis trials